John C Jr. Burnett, MD

Professor, Rochester, MN, Cardiovascular Medicine

Emailburnett.john@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where John C Jr. Burnett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

11 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
4 Not started
6 Finished

PHARMACOLOGY AND PHYSIOLOGY OF NTS ALPHA-ADRENOCEPTORS
Burnett, J. C. J., Terzic, A., Tancredi, R. & Galeno, T.
National Institutes of Health
7/1/75 → …
Project: Research project
Small Molecule Discovery for Particulate Guanylyl Cyclase Receptor B Enhancers
Burnett, J. C. J. & Sangaralingham, S. J.
Project: Research project
EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM
Burnett, J. C. J.
Project: Research project
Novel Peptide Therapeutics for Cardiorenal Protection in Heart Failure
Burnett, J. C. J.
Project: Research project
Novel Peptide Therapeutics for Hypertension
Burnett, J. C. J.
Project: Research project

37841 Citations
96 Scopus h-Index
462 Article
61 Review article
25 Editorial
13 Letter
25 More

B-type natriuretic peptide and cardiac remodelling after myocardial infarction: A randomised trial
Hubers, S. A., Schirger, J. A., Sangaralingham, S. J., Chen, Y., Burnett, J. C., Hodge, D. & Chen, H. H., 2020, (Accepted/In press) In : Heart.
Research output: Contribution to journal › Article › peer-review
Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature
Savira, F., Magaye, R., Liew, D., Reid, C., Kelly, D. J., Kompa, A. R., Sangaralingham, S. J., Burnett, J. C., Kaye, D. & Wang, B. H., Jul 1 2020, In : British Journal of Pharmacology. 177, 13, p. 2906-2922 17 p.
Research output: Contribution to journal › Review article › peer-review
3 Scopus citations
Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction
Lyle, M. A., Iyer, S. R., Redfield, M. M., Reddy, Y. N. V., Felker, G. M., Cappola, T. P., Hernandez, A. F., Scott, C. G., Burnett, J. C. & Pereira, N. L., Jan 2020, In : JACC: Heart Failure. 8, 1, p. 70-80 11 p.
Research output: Contribution to journal › Article › peer-review
10 Scopus citations
C-type natriuretic peptide: The heart's guardian angel
Sangaralingham, S. J., Chen, Y. & Burnett, J. C., Mar 1 2020, In : European heart journal. 41, 9, p. 1021-1023 3 p.
Research output: Contribution to journal › Review article › peer-review

1 Scopus citations
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients with Heart Failure with Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial
Udelson, J. E., Lewis, G. D., Shah, S. J., Zile, M. R., Redfield, M. M., Burnett, J., Parker, J., Seferovic, J. P., Wilson, P., Mittleman, R. S., Profy, A. T. & Konstam, M. A., Oct 20 2020, In : JAMA - Journal of the American Medical Association. 324, 15, p. 1522-1531 10 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations